Tokyo Tape
Sign in
← PHC Holdings

Quarterly report · Q1

6523.TEDINET S100RO21
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 47
MetricValuePeriodScopeSource row
Revenue¥81.3bn2023-04-01 → 2023-06-30Cons.Revenue IFRS
Revenue¥356.4bn2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥81.5bn2022-04-01 → 2022-06-30Cons.Revenue IFRS
Operating income¥1.7bn2023-04-01 → 2023-06-30Cons.Operating profit loss IFRS
Operating income¥2.0bn2022-04-01 → 2022-06-30Cons.Operating profit loss IFRS
Profit before tax−¥3.6bn2023-04-01 → 2023-06-30Cons.Profit loss before tax IFRS
Profit before tax¥179m2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax−¥6.3bn2022-04-01 → 2022-06-30Cons.Profit loss before tax IFRS
Net income (owners)−¥3.2bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥3.2bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)−¥7.1bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent IFRS
Net income−¥3.1bn2023-04-01 → 2023-06-30Cons.Profit loss IFRS
Net income−¥7.0bn2022-04-01 → 2022-06-30Cons.Profit loss IFRS
Total assets¥572.5bnat 2023-06-30Cons.Assets IFRS
Total assets¥561.6bnat 2023-03-31Cons.Assets IFRS
Total assets¥595.7bnat 2022-06-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥428.9bnat 2023-06-30Cons.Liabilities IFRS
Total liabilities¥422.7bnat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥143.7bnat 2023-06-30Cons.Equity IFRS
Net assets / equity¥138.8bnat 2023-03-31Cons.Equity IFRS
Net assets / equity¥137.7bnat 2022-06-30Cons.Equity IFRS
Net assets / equity¥136.1bnat 2022-03-31dCons.Equity IFRS
Equity (owners)¥144.0bnat 2023-06-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥138.0bnat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥136.9bnat 2022-06-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥54.1bnat 2023-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥60.9bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥82.1bnat 2022-06-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥95.2bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥8.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥21.4bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥1.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥3.5bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥17.5bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥5.2bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥14.4bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥40.8bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥11.9bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥-25.52023-04-01 → 2023-06-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-25.842022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥-57.262022-04-01 → 2022-06-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥-25.52023-04-01 → 2023-06-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-25.842022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥-57.262022-04-01 → 2022-06-30Cons.Diluted earnings loss per share IFRS
Equity ratio25.2%at 2023-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio24.6%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio23.0%at 2022-06-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-06-30¥568m
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥2.2bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2023-04-01 → 2023-06-30¥25.4bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.6bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2023-04-01 → 2023-06-30¥24.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2023-04-01 → 2023-06-30¥30.8bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2023-04-01 → 2023-06-30¥1.2bn
—segment totalrevenue2023-04-01 → 2023-06-30¥80.8bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥80.8bn
—segment totalsegment profit2023-04-01 → 2023-06-30¥3.9bn
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-06-30¥552m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥6.7bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentrevenue external2022-04-01 → 2022-06-30¥26.5bn
jpcrp040300-q1r_E36976-000Diabetes Managementreportable segmentsegment profit2022-04-01 → 2022-06-30¥5.5bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentrevenue external2022-04-01 → 2022-06-30¥23.4bn
jpcrp040300-q1r_E36976-000Diagnostics And Life Sciencesreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.2bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentrevenue external2022-04-01 → 2022-06-30¥31.1bn
jpcrp040300-q1r_E36976-000Healthcare Solutionsreportable segmentsegment profit2022-04-01 → 2022-06-30¥2.0bn
—segment totalrevenue2022-04-01 → 2022-06-30¥80.9bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥80.9bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥8.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 864
ItemContextValueUnit
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-337000000JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Transfer from other components of equity to retained earnings ss IFRSCurrentYTDDuration－JPY
Other ss IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember－JPY
Other ss IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember－JPY
Other ss IFRSCurrentYTDDuration－JPY
Total transactions with owners IFRSCurrentYTDDuration_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember－JPY
Total transactions with owners IFRSCurrentYTDDuration_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember-475000000JPY
Total transactions with owners IFRSCurrentYTDDuration_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember475000000JPY
Total transactions with owners IFRSCurrentYTDDuration_OtherComponentsOfEquityIFRSMember-337000000JPY
Total transactions with owners IFRSCurrentYTDDuration_EquityAttributableToOwnersOfParentIFRSMember-5936000000JPY
Total transactions with owners IFRSCurrentYTDDuration_NonControllingInterestsIFRSMember-1232000000JPY
Total transactions with owners IFRSCurrentYTDDuration-7168000000JPY
Equity IFRSCurrentQuarterInstant_ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember42698000000JPY
Equity IFRSCurrentQuarterInstant_ShareOfOtherComprehensiveIncomeOfInvestmentsAccountedForUsingEquityMethodIFRSMember319000000JPY
Equity IFRSCurrentQuarterInstant_jpcrp040300-q1r_E36976-000OtherComponentsOfEquityRelatedToDisposalGroupsClassifiedAsHeldForSaleIFRSMember475000000JPY
Equity IFRSCurrentQuarterInstant_OtherComponentsOfEquityIFRSMember44708000000JPY
Equity IFRSCurrentQuarterInstant_EquityAttributableToOwnersOfParentIFRSMember144010000000JPY
Equity IFRSCurrentQuarterInstant_NonControllingInterestsIFRSMember-320000000JPY
Equity IFRSCurrentQuarterInstant143690000000JPY
Profit loss before tax IFRSPrior1YTDDuration-6297000000JPY
Profit loss before tax IFRSCurrentYTDDuration-3588000000JPY
Depreciation expense ope cf IFRSPrior1YTDDuration7446000000JPY
Depreciation expense ope cf IFRSCurrentYTDDuration6658000000JPY
Impairment losses reversal of impairment losses ope cf IFRSPrior1YTDDuration74000000JPY
Impairment losses reversal of impairment losses ope cf IFRSCurrentYTDDuration0JPY
Gain loss from financial assets measured at fair value through profit or loss ope cf IFRSPrior1YTDDuration6127000000JPY
Gain loss from financial assets measured at fair value through profit or loss ope cf IFRSCurrentYTDDuration-294000000JPY
Interest expenses ope cf IFRSPrior1YTDDuration1024000000JPY
Interest expenses ope cf IFRSCurrentYTDDuration2353000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSPrior1YTDDuration125000000JPY
Share of loss profit of investments accounted for using equity method ope cf IFRSCurrentYTDDuration85000000JPY
Loss gain on sale of fixed assets ope cf IFRSPrior1YTDDuration-1000000JPY
Loss gain on sale of fixed assets ope cf IFRSCurrentYTDDuration-14000000JPY
Decrease increase in trade receivables ope cf IFRSPrior1YTDDuration7171000000JPY
Decrease increase in trade receivables ope cf IFRSCurrentYTDDuration8109000000JPY
Decrease increase in inventories ope cf IFRSPrior1YTDDuration-1540000000JPY
Decrease increase in inventories ope cf IFRSCurrentYTDDuration-3409000000JPY
Increase decrease in trade payables ope cf IFRSPrior1YTDDuration-5961000000JPY
Increase decrease in trade payables ope cf IFRSCurrentYTDDuration-4235000000JPY
Increase decrease in retirement benefit liability ope cf IFRSPrior1YTDDuration11000000JPY
Increase decrease in retirement benefit liability ope cf IFRSCurrentYTDDuration52000000JPY
Other changes in working capital ope cf IFRSPrior1YTDDuration-3561000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass